GR3020902T3 - Use of 15-keto-prostaglandin compound for improvement of encephalic function - Google Patents

Use of 15-keto-prostaglandin compound for improvement of encephalic function

Info

Publication number
GR3020902T3
GR3020902T3 GR960402122T GR960402122T GR3020902T3 GR 3020902 T3 GR3020902 T3 GR 3020902T3 GR 960402122 T GR960402122 T GR 960402122T GR 960402122 T GR960402122 T GR 960402122T GR 3020902 T3 GR3020902 T3 GR 3020902T3
Authority
GR
Greece
Prior art keywords
keto
improvement
prostaglandin compound
encephalic
function
Prior art date
Application number
GR960402122T
Other languages
English (en)
Inventor
Ryuji Ueno
Hiroyoshi Osama
Tomio Oda
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP8543990A external-priority patent/JPH07116135B2/ja
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of GR3020902T3 publication Critical patent/GR3020902T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR960402122T 1989-11-22 1996-08-29 Use of 15-keto-prostaglandin compound for improvement of encephalic function GR3020902T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP30383989 1989-11-22
JP761190 1990-01-17
JP8543990A JPH07116135B2 (ja) 1990-03-30 1990-03-30 ６，１５―ジケト―５―ハロプロスタグランジンｅ類

Publications (1)

Publication Number Publication Date
GR3020902T3 true GR3020902T3 (en) 1996-11-30

Family

ID=27277677

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402122T GR3020902T3 (en) 1989-11-22 1996-08-29 Use of 15-keto-prostaglandin compound for improvement of encephalic function

Country Status (9)

Country Link
US (3) US5117042A (el)
EP (1) EP0435443B1 (el)
KR (2) KR0147057B1 (el)
AT (1) ATE141793T1 (el)
CA (1) CA2030345C (el)
DE (1) DE69028289T2 (el)
DK (1) DK0435443T3 (el)
ES (1) ES2093636T3 (el)
GR (1) GR3020902T3 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101781A (zh) * 1993-02-03 1995-04-19 帝人株式会社 治疗脑血栓的药物组合物
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
US6242485B1 (en) * 1996-06-10 2001-06-05 R-Tech Ueno Endothelin antagonist
US6649653B1 (en) 1996-11-12 2003-11-18 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
US6680339B2 (en) 1996-11-12 2004-01-20 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
SK3382000A3 (en) * 1997-09-09 2000-10-09 Procter & Gamble A compound having structure of aromatic substituted prostaglandins and its use for the treatment of bone disorders
BR9811774A (pt) * 1997-09-09 2000-08-29 Procter & Gamble Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
EP0978284B1 (en) * 1997-11-28 2008-07-23 Sucampo AG Use of 15-keto-prostaglandin-e compounds as endothelin antagonists
CA2364948C (en) 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
DE60039727D1 (de) * 1999-10-15 2008-09-11 Sucampo Ag Neue Zusammensetzung enthaltend eine bicyclische Verbindung und ein Glycerid
CA2403086C (en) * 2000-03-24 2010-08-17 Sucampo Ag Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) * 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
AU2006209072B2 (en) 2005-01-27 2011-02-24 Sucampo Ag Method and composition for treating central nervous system disorders
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
US8513441B2 (en) * 2008-08-29 2013-08-20 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2429982A4 (en) 2009-01-22 2012-09-12 Apotex Pharmachem Inc METHOD FOR THE PRODUCTION OF LUBIPROSTON AND INTERMEDIATE PRODUCTS THEREOF
AU2012293157A1 (en) 2011-08-05 2014-03-13 Sucampo Ag Method for treating schizophrenia
CN104140410B (zh) * 2013-05-09 2017-12-15 江苏豪森药业集团有限公司 鲁比前列酮的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153858A3 (en) * 1984-02-29 1985-12-11 The Upjohn Company The therapeutic use of prostaglandins
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
ATE78465T1 (de) * 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.
US5106809A (en) * 1990-12-14 1992-04-21 Exxon Research And Engineering Company High activity, high yield tin modified platinum-iridium catalysts, and reforming process utilizing such catalysts

Also Published As

Publication number Publication date
EP0435443A2 (en) 1991-07-03
US5290811A (en) 1994-03-01
EP0435443A3 (en) 1993-01-27
EP0435443B1 (en) 1996-08-28
DE69028289T2 (de) 1997-01-09
US5426115A (en) 1995-06-20
CA2030345A1 (en) 1991-05-23
KR0147057B1 (ko) 1998-08-17
DK0435443T3 (da) 1996-09-16
US5117042A (en) 1992-05-26
DE69028289D1 (de) 1996-10-02
CA2030345C (en) 1998-12-08
KR910009269A (ko) 1991-06-28
KR0167745B1 (ko) 1999-01-15
ES2093636T3 (es) 1997-01-01
ATE141793T1 (de) 1996-09-15

Similar Documents

Publication Publication Date Title
EP0435443A3 (en) Use of 15-keto-prostaglandin compound for improvement of encephalic function
EP0453127A3 (en) Treatment of cataract with 15-keto-prostaglandin compounds
DE3865817D1 (el)
CS554389A3 (en) Equipment for yarn manufacture.
DE3779053D1 (el)
GB2230381B (en) Superluminescent diode
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
GR3019760T3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
PH25605A (en) 16-dehydro-vitamin d3-derivatives, medicament contatining said compounds
EP0411733A3 (en) 11-beta-aryle-gona-4,9-dien-3-ones
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
EP0430551A3 (en) Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
EP0405905A3 (en) Use of isoxazolin-3-one derivatives as antidepressants
GR3022217T3 (en) Treatment of cataract with prostacyclin compounds
EP0261439A3 (en) Medicament for curing arteriosclerosis, comprising pyrimido (2,1-b) benzothiazole derivative
GR3017775T3 (en) Phenoxy-heterocyclic compounds.
AR245225A1 (es) Composiciones para el tratamiento de cuero.
EG19467A (en) Self aspirating syringe.
DE3882331D1 (en) Dose.
AR244676A1 (es) Un procedimiento para la preparacion de ranitidina.
EP0432983A3 (en) Novel compounds of the diterpene type
GB8925969D0 (en) Vapouriser